Results of physiological parameters. by Vanessa Wellauer (18408477)

Subjects:

Results of recovery parameters. by Vanessa Wellauer (18408477)

Subjects:

Raw data used for statistical analysis. by Vanessa Wellauer (18408477)

Subjects:

Schematic representation of the experimental protocol over time. by Vanessa Wellauer (18408477)

Subjects:

Pairwise comparisons of the intervention effects by time point for physiological parameters. by Vanessa Wellauer (18408477)

Subjects:

CONSORT flowchart of participants. by Vanessa Wellauer (18408477)

Subjects:

Pairwise comparisons of the intervention effects by time point for recovery parameter. by Vanessa Wellauer (18408477)

Subjects:

(a)(b)(c). Relationship between the OHAT-J score for “lips” or “saliva” or “dentures” and the BI at discharge. by Misaki Nakamura (756854)

The complex interplay between SGLT-2is, RAAS, and glucose metabolism in type 2 diabetes mellitus patients. by Ningning Wang (560944)

Subjects:

Time Course of the RAAS. by Ningning Wang (560944)

Subjects:

Effects of SGLT-2is during the time course. by Ningning Wang (560944)

Subjects:

Changes of physical and biochemical indicators from baseline and difference between DKD and non-DKD patients. by Ningning Wang (560944)

Subjects:

Baseline characteristics between DKD and non-DKD patients. by Ningning Wang (560944)

Subjects:

Flow diagram of patient recruitment. by Ningning Wang (560944)

Subjects:

Spearman correlation analysis of the RAAS and glucose metabolism indicators before and after treatment in DKD and non-DKD patients. by Ningning Wang (560944)

Subjects:

Multiple linear regression analysis of the RAAS and glucose metabolism indicators before and after treatment in DKD and non-DKD patients. by Ningning Wang (560944)

Subjects:

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P_i-induced VSMCs. …”

RcbA and RcbB co-operatively decrease motility independent of CaCl₂ concentration. by Shobnom Mustaree (21728815)

<i>Porphyromonas gingivalis</i> LPS pretreated by ozone ultrafine bubble water induces decreased TLR2 activation. by Mana Endo (22430706)

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”